Thomas SN - Search Results

1

Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.

Kim J, Thomas SN. Kim J, et al. Among authors: thomas sn. Pharmacol Rev. 2022 Oct;74(4):1146-1175. doi: 10.1124/pharmrev.121.000500. Pharmacol Rev. 2022. PMID: 36180108 Free PMC article. Review.

2

Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy.

Francis DM, Thomas SN. Francis DM, et al. Among authors: thomas sn. Adv Drug Deliv Rev. 2017 May 15;114:33-42. doi: 10.1016/j.addr.2017.04.011. Epub 2017 Apr 25. Adv Drug Deliv Rev. 2017. PMID: 28455187 Free PMC article. Review.

3

Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.

Kersh AE, Ng S, Chang YM, Sasaki M, Thomas SN, Kissick HT, Lesinski GB, Kudchadkar RR, Waller EK, Pollack BP. Kersh AE, et al. Among authors: thomas sn. J Clin Pharmacol. 2018 Jan;58(1):7-24. doi: 10.1002/jcph.1028. Epub 2017 Nov 14. J Clin Pharmacol. 2018. PMID: 29136276 Free PMC article. Review.

4

Winner of the society for biomaterials young investigator award for the annual meeting of the society for biomaterials, April 11-14, 2018, Atlanta, GA: S-nitrosated poly(propylene sulfide) nanoparticles for enhanced nitric oxide delivery to lymphatic tissues.

Schudel A, Sestito LF, Thomas SN. Schudel A, et al. Among authors: thomas sn. J Biomed Mater Res A. 2018 Jun;106(6):1463-1475. doi: 10.1002/jbm.a.36348. Epub 2018 Mar 5. J Biomed Mater Res A. 2018. PMID: 29352735 Free PMC article.

5

Augmenting the synergies of chemotherapy and immunotherapy through drug delivery.

Kim J, Manspeaker MP, Thomas SN. Kim J, et al. Among authors: thomas sn. Acta Biomater. 2019 Apr 1;88:1-14. doi: 10.1016/j.actbio.2019.02.012. Epub 2019 Feb 12. Acta Biomater. 2019. PMID: 30769136 Review.

6

Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy.

Francis DM, Manspeaker MP, Schudel A, Sestito LF, O'Melia MJ, Kissick HT, Pollack BP, Waller EK, Thomas SN. Francis DM, et al. Among authors: thomas sn. Sci Transl Med. 2020 Sep 30;12(563):eaay3575. doi: 10.1126/scitranslmed.aay3575. Sci Transl Med. 2020. PMID: 32998971 Free PMC article.

7

Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy.

Manspeaker MP, Thomas SN. Manspeaker MP, et al. Among authors: thomas sn. Adv Drug Deliv Rev. 2020;160:19-35. doi: 10.1016/j.addr.2020.10.004. Epub 2020 Oct 12. Adv Drug Deliv Rev. 2020. PMID: 33058931 Free PMC article.

8

Poly(cyclodextrin)-Polydrug Nanocomplexes as Synthetic Oncolytic Virus for Locoregional Melanoma Chemoimmunotherapy.

Kim J, Sestito LF, Im S, Kim WJ, Thomas SN. Kim J, et al. Among authors: thomas sn. Adv Funct Mater. 2020 Apr 20;30(16):1908788. doi: 10.1002/adfm.201908788. Epub 2020 Feb 24. Adv Funct Mater. 2020. PMID: 33071710 Free PMC article.

9

Lymph-directed nitric oxide increases immune cell access to lymph-borne nanoscale solutes.

Sestito LF, Thomas SN. Sestito LF, et al. Among authors: thomas sn. Biomaterials. 2021 Jan;265:120411. doi: 10.1016/j.biomaterials.2020.120411. Epub 2020 Sep 18. Biomaterials. 2021. PMID: 33080460 Free PMC article.

10

In Situ Crosslinked Hydrogel Depot for Sustained Antibody Release Improves Immune Checkpoint Blockade Cancer Immunotherapy.

Kim J, Francis DM, Thomas SN. Kim J, et al. Among authors: thomas sn. Nanomaterials (Basel). 2021 Feb 12;11(2):471. doi: 10.3390/nano11020471. Nanomaterials (Basel). 2021. PMID: 33673289 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page